Colangitis por obstrucción de asa aferente tras duodenopancreatectomía cefálica

Llàcer-Millán, Erik; Griñó, P; Hernández, Juan Ángel Fernández; Paricio, Pascual Parrilla

doi:10.1016/j.ciresp.2015.08.004

Cited by 4 publications

(1 citation statement)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There are few studies regarding the diagnosis and treatment of this clinical entity the majority being case reports. Ruiz Pardo et al [8] presented a case report of a 54-year-old woman who underwent a cephalic pancreaticoduodenectomy due to pancreatic head adenocarcinoma who -after intensive chemotherapy, presented tumor recurrence at afferent loop level, appearing as cholangitis, which was surgically resolved without any complications. The case we present is very similar to Ruiz Pardo´s report [8], however, our patient was managed with advanced therapeutic endoscopy techniques, with results equally effective to those previously described.…”

Section: Discussionmentioning

confidence: 99%

Management of Obstructed Afferent-Loop due to Recurrence of Pancreatic Adenocarcinoma using an Enteral Self-Expanding Metal Stent

Ramos¹

2017

GHOA

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Management of Obstructed Afferent-Loop due to Recurrence of Pancreatic Adenocarcinoma using an Enteral Self-Expanding Metal Stent

Ramos¹

2017

GHOA

View full text Add to dashboard Cite

show abstract

Early and late effects of endoscopic interventions in patients with malignant afferent loop syndrome: A single‐center experience and literature review

Yamamoto,

Itoi,

Matsunami

et al. 2023

J Hepato Biliary Pancreat

View full text Add to dashboard Cite

Background/PurposeAfferent loop syndrome (ALS) is a rare adverse event after gastrointestinal surgery requiring appropriate early decompression treatment. Several endoscopic interventions have been attempted for treatment, including endoscopic enteral metal stent placement (EMSP), endoscopic ultrasound (EUS)‐guided entero‐enterostomy (EUS‐EE), and EUS‐guided hepaticogastrostomy (EUS‐HGS). However, there are limited data on outcomes, including duration of stent patency. In this study, we evaluated the usefulness of each endoscopic intervention for malignant ALS.MethodsWe retrospectively investigated nine patients with malignant ALS who underwent EMSP, EUS‐EE, or EUS‐HGS. Information on technical success, clinical efficacy, adverse events, stent dysfunction, and overall survival was collected and analyzed.ResultsThe most common symptoms were abdominal pain and cholangitis. ALS was treated by EMSP in three patients, EUS‐EE in three patients, and EUS‐HGS in three patients. Stent placement was successful and clinically effective in all patients with no adverse events. During follow‐up, stent dysfunction occurred in two patients treated by EUS‐HGS. Eight patients died of primary disease during a median follow‐up of 157 days.ConclusionsEach of the available endoscopic interventions for malignant ALS can be expected to produce similar outcomes, including duration of stent patency. The choice of endoscopic intervention should be made based on the characteristics of each treatment.

show abstract